Trial results

$OCGN — OCU410ST

Ocugen, Inc. (OCGN) OCU410ST: trial results in Stargardt Disease, 2027.

Research by Catalyst Intel

The catalyst

"2027 Topline Data; BLA submission"

— Ocugen, 8-K filed 2026-09-08 · the filing. Checked word for word against the stored document when this page was built; a sentence that did not check out would not be here.

Event id

OCGN-OCU410ST-2026

Company

Ocugen, Inc.

Kind

Trial results

Indication

Stargardt Disease

Window

2027-01-01 – 2027-12-31

Status

slate

The bar

No bar has been published for this event yet.

Verdicts

No verdict has been published for this event yet.